Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “THE UNITED STATES OF AMERICA AS REPRESENTED BY THE”

783 pharma patents match "THE UNITED STATES OF AMERICA AS REPRESENTED BY THE" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 783
Index total 30,257
Page 2 / 33

Quick answer

This filtered view shows 783 pharmaceutical patents matching "THE UNITED STATES OF AMERICA AS REPRESENTED BY THE" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

783 results for “THE UNITED STATES OF AMERICA AS REPRESENTED BY THE” · 30,257 patents in full index Clear search

  1. US 11254667

    Substituted imidazo[1,2-A]pyridines as IRAK 1/4 and flt3 inhibitors

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Feb 22, 2022 · Expires Feb 17, 2042

    granted

  2. US 11160859

    Materials and methods for respiratory disease control in canines

    THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION · Granted Nov 2, 2021 · Expires Oct 28, 2041

    granted

  3. US 11154608

    Dengue virus e-glycoprotein polypeptides containing mutations that eliminate immunodominant cross-reactive epitopes

    The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Oct 26, 2021 · Expires Oct 21, 2041

    granted

  4. US 11136372

    ApoC-II mimetic peptides

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Oct 5, 2021 · Expires Sep 30, 2041

    granted

  5. US 11078239

    Prefusion PIV F immunogens and their use

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Aug 3, 2021 · Expires Jul 29, 2041

    granted

  6. US 11052057

    Use of cysteamine and derivatives thereof to suppress tumor metastases

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Jul 6, 2021 · Expires Jul 1, 2041

    granted

  7. US 11041008

    Heterodimers of IL-15 and IL-15R alpha to increase thymic output and to treat lymphopenia

    The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Jun 22, 2021 · Expires Jun 17, 2041

    granted

  8. US 11026947

    ALK2 inhibitors and methods for inhibiting BMP signaling

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Jun 8, 2021 · Expires Jun 3, 2041

    granted

  9. US 10934360

    Human monoclonal antibodies against EPHA4 and their use

    The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Mar 2, 2021 · Expires Feb 25, 2041

    granted

  10. US 10898565

    Compositions, methods and uses for dengue virus serotype-4 constructs

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jan 26, 2021 · Expires Jan 21, 2041

    granted

  11. US 10894816

    Use of IL-15 to increase thymic output and to treat lymphopenia

    The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Jan 19, 2021 · Expires Jan 14, 2041

    granted

  12. US 10849970

    Antibody evolution immunogens

    The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Dec 1, 2020 · Expires Nov 26, 2040

    granted

  13. US 10828364

    Method for reducing a myeloid derived suppressor cell population with cationic lipid vaccine compositions

    THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SEC. OF THE DEPT. OF HEALTH AND HUMAN SERVICES · Granted Nov 10, 2020 · Expires Nov 5, 2040

    granted

  14. US 10822608

    Oligonucleotide analogues targeting human LMNA

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Nov 3, 2020 · Expires Oct 29, 2040

    granted

  15. US 10767184

    Chimeric antigen receptors targeting B-cell maturation antigen

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Sep 8, 2020 · Expires Sep 3, 2040

    granted

  16. US 10695414

    Modulation of replicative fitness by deoptimization of synonymous codons

    THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION · Granted Jun 30, 2020 · Expires Jun 25, 2040

    granted

  17. US 10683363

    Targeting intracellular target-binding determinants with intracellular antibodies

    The United States of America as represented by the Department of Veteran Affairs · Granted Jun 16, 2020 · Expires Jun 11, 2040

    granted

  18. US 10640771

    Compositions and methods for treating and preventing macular degeneration

    THE UNITED STATES OF AMERICA AS REPRESENTED BY THE · Granted May 5, 2020 · Expires Apr 30, 2040

    granted

  19. US 10584355

    Chimpanzee adenoviral vector-based filovirus vaccines

    The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Mar 10, 2020 · Expires Mar 5, 2040

    granted

  20. US 10568956

    Dengue virus e-glycoprotein polypeptides containing mutations that eliminate immunodominant cross-reactive epitopes

    The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Feb 25, 2020 · Expires Feb 20, 2040

    granted

  21. US 10538590

    Photosensitizing antibody-fluorophore conjugates

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Jan 21, 2020 · Expires Jan 16, 2040

    granted

  22. US 10538749

    Mutant OPAA enzymes with increased catalytic efficiency on cyclosarin

    The United States of America as represented by the Secretary of the Army · Granted Jan 21, 2020 · Expires Jan 16, 2040

    granted

  23. US 10507187

    Regenerative tissue grafts and methods of making same

    The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Dec 17, 2019 · Expires Dec 12, 2039

    granted

  24. US 10494435

    Human monoclonal antibodies specific for CD22

    The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Dec 3, 2019 · Expires Nov 28, 2039

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.